XML 34 R16.htm IDEA: XBRL DOCUMENT v3.25.2
Equity
 6 Months Ended
Jun. 30, 2025
Equity [Abstract]  
Equity Equity
Common Stock
In connection with the stock compensation vesting and stock option exercises described in Note 12, the Company issued 1,300,135 shares of Common Stock during the six months ended June 30, 2025.
Dividends
On February 18, 2025, the Company's Board of Directors approved a quarterly dividend program. Under the program, subject to quarterly approval and declaration by the Board of Directors, dividends will be payable on the third Wednesday of the third month of each calendar quarter to stockholders of record as of the first Wednesday of that same month.
In February 2025, the Board of Directors declared a quarterly dividend of $0.07 per share, totaling $13.0 million. In May 2025, the Board of Directors declared a quarterly dividend of $0.07 per share, totaling $12.9 million. Dividends paid were $25.6 million for the six months ended June 30, 2025.
Stock Repurchase Program
In September 2024, the Board of Directors approved a reset of the share repurchase program authorizing the Company to repurchase up to $1.0 billion of its outstanding shares of Common Stock. The stock repurchase program does not obligate the Company to purchase any particular number of shares, and the timing and exact amount of any repurchases will depend on various factors, including market pricing, business, legal, accounting, and other considerations.
During the six months ended June 30, 2025, the Company repurchased 2,628,041 shares of Common Stock for $71.9 million, excluding excise tax. As of June 30, 2025, $750.0 million of the authorization for future repurchases of Common Stock remained available.
Accumulated Other Comprehensive Income (Loss)
The changes in accumulated other comprehensive income (loss) ("AOCI"), net of tax, for the six months ended June 30, 2025 and 2024 were as follows:
Six Months Ended June 30, 2025
(in thousands)Foreign currency translationUnrealized gains (losses) on hedging activitiesTotal
Balance at December 31, 2024$(80,720)$10,093 $(70,627)
Other comprehensive income (loss) before reclassifications161 (5,710)(5,549)
Reclassifications from AOCI to income— (2,431)(2,431)
Balance at March 31, 2025(80,559)1,952 (78,607)
Other comprehensive income (loss) before reclassifications16,278 (1,469)14,809 
Reclassifications from AOCI to income— (2,453)(2,453)
Balance at June 30, 2025$(64,281)$(1,970)$(66,251)
Six Months Ended June 30, 2024
(in thousands)Foreign currency translationUnrealized gains on hedging activitiesTotal
Balance at December 31, 2023$(56,031)$3,263 $(52,768)
Other comprehensive (loss) income before reclassifications(5,548)18,807 13,259 
Reclassifications from AOCI to income— (5,267)(5,267)
Balance at March 31, 2024(61,579)16,803 (44,776)
Other comprehensive (loss) income before reclassifications(4,154)7,247 3,093 
Reclassifications from AOCI to income— (5,623)(5,623)
Balance at June 30, 2024$(65,733)$18,427 $(47,306)
The Company reclassified amounts from AOCI into the condensed consolidated statements of operations within interest expense related to the interest rate swaps. Associated with these reclassifications, the Company recorded tax expense of $0.7 million and $1.6 million for the three months ended June 30, 2025 and 2024, respectively, and tax expense of $1.3 million and $3.0 million for the six months ended June 30, 2025 and 2024, respectively. The interest rate swaps are discussed in Note 10.